References
- Salifiska E, Danysz W, Lazarewicz JW. The role of excitotoxicity in neurodegeneration. Folia Neuropathol 2005; 43: 322–339
- Lazarewicz JW, Salifiska E, Stafiej A, et al. NMDA receptors andnitric oxide regulate prostaglandin D2 synthesis in the rabbit hippocampus in vivo. Acta Neurobiol Exp 2000; 60: 427–435
- Lazarewicz JW, Wróblewski JT, Palmer MR, et al. Activation of N-methyl-D-aspartate-sensitive glutamate receptors stimulates arachidonic acid release in primary cultures of cerebellar granule cells. Neuropharmacology 1988; 27: 765–769
- Matyja E, Nagafiska E, Taraszewska A, et al. The mode of spinalmotor neuron degeneration in a model of slow glutamate excitotoxicity in vitro. Point Neuropathol 2005; 43: 7–13
- Matyja E, Taraszewska A, Nagafiska E, et al. Autophagic degeneration of motor neurons in a model of slow glutamate excitotoxicity in vitro. Ultrastruct Pathol 2005; 29: 331–339
- Niebrój-Dobosz I, Dziewulska D, Janik P. Auto-antibodies againstprotein soft spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS). Point Neuropathol 2006; 4: 191–196
- Rothstein JD. Excitotoxicity and neurodegeneration in amyo-trophic lateral sclerosis. Clin Neurosci 1995; 3: 348–359
- Dunlop J, Beal-Mcllvain H, She Y, et al. Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis. J Neurosci 2003; 23: 1688–1696
- Bendotti C, Tortarolo M, Suchak SK, et al. Transgenic SODIG93Amice develop reduced GLT-1 spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem 2001; 79: 737–746
- Sasaki S, Komori T, Iwata M. Excitotoxicity amino acid transporter 1 and 2 immunoreactivity in the spinal cord in amyotrophic lateral sclerosis. Acta Neuropathol 2000; 100: 138–144
- Tortarolo M, Crossthwaite AJ, Conforti L, et al. Expression of SOD1G93A or wild-type SOD1 in primary cultures of astrocytes down-regulates the glutamate transporter GLT-1: Lack of involvement of oxidative stress. J Neurochem 2004; 88: 481–493
- Matyja E, Taraszewska A, Nagafiska E, et al. Astroglial alterations in amyotrophic lateral sclerosis (ALS) model of slow glutamate excitotoxicity in vitro. Point Neuropathol 2006; 44: 183–190
- Rafalowska J, Podlecka A. Does the pathological factor in amyotrophic lateral sclerosis (ALS) damage also astrocytes? Folia Neuropathol 1998; 36: 87–93
- Rafalowska J, Fidziafiska A, Dziewulska D, et al. Progression of morphological changes within CNS in a transgenic rat model of familial amyotrophic lateral sclerosis. Folia Neuropathol 2006; 44: 162–174
- Gadamski R, Chrapusta Si, Wojda R, et al. Morphological changes and selective loss of motoneurons in the lumbal part of the spinal cord in a rat model of familial amyotrophic lateral sclerosis (fALS). Folia Neuropathol 2006; 44: 154–161
- Fidziafiska A, Gadamski R, Rafalowska J, et al. Ultrastructural changes in lumbal spinal cord in transgenic SOD1G93A rats. Folia Neuropathol 2006; 44: 175–182
- Wong NK, He BP, Strong Mi. Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J Neuropathol Exp Neurol 2000; 59: 972–982
- Al-Chalabi A, Andersen PM, Nilsson P, et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet 1999; 8: 157–164
- Julien JP, Mellecamps S, Kriz J. Cytoskeletal defects in amyo-trophic lateral sclerosis (motor neuron disease). Novartis Found Symp 2005; 264: 183–192
- Wood JD, Neaujeux TP, Shaw Pi. Protein aggregation in motor neuron disorders. Neuropathol Appl Neurobiol 2003; 29: 529–545
- Yang W, Sopper MW, Leystra-Lantz C, et al. Microtubule-associated tau protein positive neuronal and glial inclusions in ALS. Neurology 2003; 61: 1766–1773
- Maga G, Hubscher U. Proliferating cell nuclear antigen (PCNA): A dancer with many partners. J Cell Sci 2003; 116: 3051–3060
- Kirby J, Halligan E, Babtista MJ, et al. Mutant SOD1 alters the motor neuronal transcriptome: Implications for familial ALS. Brain 2005; 128: 1686–1706
- Vanoni C, Massari S, Losa M, et al. Increased internalization and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS). J Cell Sci 2004; 117: 5417–5426
- Strange RW, Yong CW, Smith W, et al. Molecular dynamics using atomic-resolution structure reveal structural fluctuations that may lead to polymerization of human Cu—Zn superoxide dismutase. Proc Natl Acad Sci USA 2007; 104: 10040–10044